Cargando…

Liver fibrosis and adverse outcomes in COVID-19

Detalles Bibliográficos
Autor principal: Huang, Jianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015429/
https://www.ncbi.nlm.nih.gov/pubmed/33994131
http://dx.doi.org/10.1016/j.dld.2021.03.024
_version_ 1783673674440638464
author Huang, Jianmin
author_facet Huang, Jianmin
author_sort Huang, Jianmin
collection PubMed
description
format Online
Article
Text
id pubmed-8015429
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-80154292021-04-02 Liver fibrosis and adverse outcomes in COVID-19 Huang, Jianmin Dig Liver Dis Correspondence Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2021-07 2021-04-01 /pmc/articles/PMC8015429/ /pubmed/33994131 http://dx.doi.org/10.1016/j.dld.2021.03.024 Text en © 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Huang, Jianmin
Liver fibrosis and adverse outcomes in COVID-19
title Liver fibrosis and adverse outcomes in COVID-19
title_full Liver fibrosis and adverse outcomes in COVID-19
title_fullStr Liver fibrosis and adverse outcomes in COVID-19
title_full_unstemmed Liver fibrosis and adverse outcomes in COVID-19
title_short Liver fibrosis and adverse outcomes in COVID-19
title_sort liver fibrosis and adverse outcomes in covid-19
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015429/
https://www.ncbi.nlm.nih.gov/pubmed/33994131
http://dx.doi.org/10.1016/j.dld.2021.03.024
work_keys_str_mv AT huangjianmin liverfibrosisandadverseoutcomesincovid19